Matches in Wikidata for { <http://www.wikidata.org/entity/Q47391049> ?p ?o ?g. }
- Q47391049 description "2017 nî lūn-bûn" @default.
- Q47391049 description "2017年の論文" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年学术文章" @default.
- Q47391049 description "2017年學術文章" @default.
- Q47391049 description "2017年學術文章" @default.
- Q47391049 description "2017年學術文章" @default.
- Q47391049 description "2017年學術文章" @default.
- Q47391049 description "2017年學術文章" @default.
- Q47391049 description "2017년 논문" @default.
- Q47391049 description "article científic" @default.
- Q47391049 description "article scientific" @default.
- Q47391049 description "article scientifique" @default.
- Q47391049 description "articol științific" @default.
- Q47391049 description "articolo scientifico" @default.
- Q47391049 description "artigo científico" @default.
- Q47391049 description "artigo científico" @default.
- Q47391049 description "artigo científico" @default.
- Q47391049 description "artikel ilmiah" @default.
- Q47391049 description "artikull shkencor" @default.
- Q47391049 description "artikulong pang-agham" @default.
- Q47391049 description "artykuł naukowy" @default.
- Q47391049 description "artículo científico publicado en 2017" @default.
- Q47391049 description "artículu científicu" @default.
- Q47391049 description "bilimsel makale" @default.
- Q47391049 description "bài báo khoa học" @default.
- Q47391049 description "naučni članak" @default.
- Q47391049 description "scienca artikolo" @default.
- Q47391049 description "scientific article published on 14 November 2017" @default.
- Q47391049 description "scientific article published on 14 November 2017" @default.
- Q47391049 description "scientific article published on 14 November 2017" @default.
- Q47391049 description "teaduslik artikkel" @default.
- Q47391049 description "tieteellinen artikkeli" @default.
- Q47391049 description "tudományos cikk" @default.
- Q47391049 description "vedecký článok" @default.
- Q47391049 description "vetenskaplig artikel" @default.
- Q47391049 description "videnskabelig artikel" @default.
- Q47391049 description "vitenskapelig artikkel" @default.
- Q47391049 description "vitskapeleg artikkel" @default.
- Q47391049 description "vědecký článek" @default.
- Q47391049 description "wetenschappelijk artikel" @default.
- Q47391049 description "wissenschaftlicher Artikel" @default.
- Q47391049 description "επιστημονικό άρθρο" @default.
- Q47391049 description "мақолаи илмӣ" @default.
- Q47391049 description "наукова стаття, опублікована в листопаді 2017" @default.
- Q47391049 description "научна статия" @default.
- Q47391049 description "научная статья" @default.
- Q47391049 description "научни чланак" @default.
- Q47391049 description "научни чланак" @default.
- Q47391049 description "מאמר מדעי" @default.
- Q47391049 description "مقالة علمية نشرت في 14 نوفمبر 2017" @default.
- Q47391049 description "১৪ নভেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q47391049 description "บทความทางวิทยาศาสตร์" @default.
- Q47391049 description "სამეცნიერო სტატია" @default.
- Q47391049 name "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 name "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 type Item @default.
- Q47391049 label "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 label "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 prefLabel "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 prefLabel "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 P1433 Q47391049-1C2488E3-BD53-44B7-9030-FD2EB8C8B3F1 @default.
- Q47391049 P1476 Q47391049-023ED7F4-852A-4225-A111-7D6A76963169 @default.
- Q47391049 P2093 Q47391049-276943EE-EB5A-467B-A8EA-61066CE247BD @default.
- Q47391049 P2093 Q47391049-36556250-9DFE-4B27-A067-185B7969996D @default.
- Q47391049 P2093 Q47391049-435376C9-2B21-40D8-AF82-DCEEB9C7EE0A @default.
- Q47391049 P2093 Q47391049-480E408F-155A-4A68-B521-D9736025AA95 @default.
- Q47391049 P2093 Q47391049-48C4C023-D05E-4089-8939-FBE1E9B1A40A @default.
- Q47391049 P2093 Q47391049-4D774FD6-6519-4FA1-BD62-973EB6B18F66 @default.
- Q47391049 P2093 Q47391049-4EBFB422-F4D5-4C89-9E0F-3370F8033CDC @default.
- Q47391049 P2093 Q47391049-96A530CB-E425-47E2-BFB5-6986A594B787 @default.
- Q47391049 P2093 Q47391049-F8D94161-EC10-4A7A-B345-CCF1FC86BBD6 @default.
- Q47391049 P2093 Q47391049-FCB0A81B-C9E7-4B77-9433-EDE058D2DFFF @default.
- Q47391049 P304 Q47391049-7DD344A4-C430-4612-BD74-6C648742AEC9 @default.
- Q47391049 P31 Q47391049-39F38819-4469-4399-87D0-9AFADB71F15E @default.
- Q47391049 P356 Q47391049-F4A53B3A-A88D-4E4A-9977-C0F5BD882023 @default.
- Q47391049 P478 Q47391049-93259EC5-DD99-41A6-A2D1-B5C5D673E885 @default.
- Q47391049 P50 Q47391049-653F89F0-A8F6-4EC1-8E71-CD106F28FC28 @default.
- Q47391049 P50 Q47391049-6E16F2A0-9BEC-4A6B-B2B5-F699A821C779 @default.
- Q47391049 P50 Q47391049-91447406-3331-4B03-9F69-DF14CA722C9A @default.
- Q47391049 P50 Q47391049-B4E3B7E7-8F0C-4682-8CCE-2F1C0BBA0B6B @default.
- Q47391049 P50 Q47391049-C76250CD-33B0-43FC-9B45-9616B6624979 @default.
- Q47391049 P50 Q47391049-E01769CD-8C11-4AEC-9DAB-BCAE6139AFFA @default.
- Q47391049 P50 Q47391049-E62F3559-FEAB-4868-8FB3-1A24F52D0770 @default.
- Q47391049 P50 Q47391049-E7F59E19-7043-4350-A11F-8637ED1FE5F6 @default.
- Q47391049 P577 Q47391049-B940A36C-61BB-4806-9932-ADB56A8A8216 @default.
- Q47391049 P698 Q47391049-45CA1711-EB15-435E-8AE4-14040195528F @default.
- Q47391049 P921 Q47391049-E9DDBC9F-8F57-4294-97A3-E1DCC0B2B0BB @default.
- Q47391049 P356 J.EJCA.2017.10.014 @default.
- Q47391049 P698 29149761 @default.
- Q47391049 P1433 Q332260 @default.
- Q47391049 P1476 "Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial." @default.
- Q47391049 P2093 "Agnieszka Wozniak" @default.
- Q47391049 P2093 "Alan Anthoney" @default.
- Q47391049 P2093 "Branko Zakotnik" @default.
- Q47391049 P2093 "Carla van Herpen" @default.